Global Rheumatoid Arthritis Diagnosis Market: Industry Analysis and Forecast (2020-2026) by Method, End User and Region

Global Rheumatoid Arthritis Diagnosis Market size is expected to reach US$ 35708.57 Mn. by year 2026 at a CAGR of 4.6% during the forecast period. The global Rheumatoid Arthritis Diagnosis market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Rheumatoid Arthritis Diagnosis market report also provides trends by market segments, technology, and investment with a competitive landscape. Global Rheumatoid Arthritis Diagnosis Market To know about the Research Methodology :- Request Free Sample Report

Global Rheumatoid Arthritis Diagnosis Market Overview

Rheumatoid arthritis (RA) is a type of chronic autoimmune disease. In this condition person's immune system mistakes the body's healthy tissues as a foreign invader. It's also a systemic disease meaning it can affect and spread in the whole body. Symptoms of RA include inflammation, swelling, pain, and others around joints as well as other body organs. Firstly, it affects hands and feet. However, it can affect any joint. Some of its major symptoms are pain & stiffness around one or more joints, symmetrical joint involvement, and problems around joint structure, pain, dizziness while walking, constant feeling or sense of tiredness, fever, loss of mobility, weight loss & weakness. Rheumatoid arthritis can be of different types such as seropositive RA, seronegative RA, and juvenile idiopathic arthritis (JIA). It affects adults of any age group but people ranging between the age of 40 to 60 are diagnosed with RA most and is more common in women than men. Patient symptoms govern the diagnosis of RA, a physical examination, results of X-ray and blood & urine test.

Global Rheumatoid Arthritis Diagnosis Market Dynamics

Increasing aging and geriatric population coupled, the prevalence of rheumatoid arthritis globally are the major factors that are driving the market growth. For instance, as per the data of the National Center for Biotechnology of the US, the number of people suffering from RA is anticipated to reach 579,915 by 2030 from 422,309 in 2015. Including the expenditure of 273 MN on modifying antirheumatic drugs. Although there is no permanent cure for rheumatoid arthritis, early detection & proper treatment such as surgery changed lifestyle can limit & reduce the damage of joints. Moreover, high consumption of fried and processed food that includes artificial flavor, chemicals, and other food additives as an ingredient can cause RA as well. Thus, the market for RA diagnosis is expected to record high growth. Additionally, increased obesity among people and a rising number of people addicted to smoking cigarettes impacted in a way or the growth of the RA diagnosis market. Cigarette smoking reportedly increases the risk of rheumatoid arthritis plus obsessed people are at great risk of contracting this disease than people whose weight is high. As per the made created by Dr. Finkelisten and his assistants at duke & the center for disease control projected that the rate of obesity in the US will be at 40% by 2030. Increased knowledge of geriatric people about Rheumatoid arthritis combined with an adequate healthcare system is impacting positively on the market growth as well. However, certain factors such as the high cost related to the diagnostic test kits, various government rules & regulations, and delays in the approval of drugs for the medications are restraining the market growth.

Global Rheumatoid Arthritis Diagnosis Market Segment Analysis

Global Rheumatoid Arthritis Diagnosis MarketBased on the method, the segment of imaging test is termed as the most specific and popular test for diagnosing and treating rheumatoid arthritis. Doctors may choose this test to track the progression of RA in the patient's body. MRI and CT scan assist the doctor in identifying severeness of the diseases. Although, every test is unique for diagnostic purposes. Moreover, people suffering from RA reportedly have elevated C - reactive protein (CRP) level or sed rate for which a blood test is performed to detect the exact level. Whereas, the antinuclear body is another common laboratory test used for diagnosing RA. This test is performed to identify various levels of antibodies that may be present in a patient's blood with some type of arthritis. Other tests, like the uric acid test that helps in determining the level of uric acid in the body, leads to the formulations of gout in the body which is also an inflammatory disorder and is not autoimmune. Uric acids are present in food & drinks taking specific medications can also increase the level of uric acid in the body. Uric acid gets deposited in synovial tissues especially, in the elbow, hand, and feet. Thus, propelling RA diagnostic market growth By end-user, the market is categorized into hospitals, diagnostic clinics, and ambulatory surgical centers. The segment of hospital dominated the majority market due to preference of patients preferring visits to the hospital for diagnostic and treatment of RA in the body. Moreover, advancement in the technology and adoption philosophy or Treat to Target impacted positively on the growth of the market. Whilst, diagnostic clinics have also seen growth in recent years because of the increased number of people visiting diagnostic clinics to detect the RA these private labs are easy to reach and provides quicker results followed by the ambulatory surgical centers where a patient undergoes the operation and is discharged on the same day. Though, most of the people suffering from RA don't require surgery.

Global Rheumatoid Arthritis Diagnosis Market Regional Insights:

Europe and North America dominated the global Rheumatoid arthritis diagnosis market. As per MMR the report, the prevalence of RA is high in both regions. According to the report published By the (CDC) Center for Disease Control and Prevention in 2018 states that around 54 million people were suffering from rheumatoid arthritis in the US alone. This high number of patients and prevalence of RA requires effective diagnosis and treatment of RA. Thus, the market for RA is anticipated to witness substantial growth in the forecast period. Moreover, the availability of adequate RA testing kits for the diagnostic clinics and hospitals High commercialization of rapid rheumatoid arthritis is anticipated to increase the demand for monitoring test kits further impacted positively on the region's market. Currently, In Asia Pacific, the prevalence of RA is relatively low in developing and developed nations. Though, the rising geriatric population in countries like China and Japan due to their child policy is projected to increase the prevalence of RA in the region and eventually leading towards the market growth of the RA diagnostic. Additionally, with the rising case, the demand for RA testing kits has surged due to which t commercialization has increased through distribution channels to make sure kits are available in a possible way combined with the developed healthcare system and increased investment in the field of diagnostics impacting positively on the market growth. With China, Japan, and India contributing most to the region's market growth. Global Rheumatoid Arthritis Diagnosis Market The objective of the report is to present a comprehensive analysis of the Global Rheumatoid Arthritis Diagnosis market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Rheumatoid Arthritis Diagnosis Market dynamics, structure by analyzing the market segments and project the Global Rheumatoid Arthritis Diagnosis Market size. Clear representation of competitive analysis of key players by Method, price, financial position, Method portfolio, growth strategies, and regional presence in the Global Rheumatoid Arthritis Diagnosis Market make the report investor’s guide.

Global Rheumatoid Arthritis Diagnosis Market Scope: Inquire before buying

Global Rheumatoid Arthritis Diagnosis Market

Global Rheumatoid Arthritis Diagnosis Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global Rheumatoid Arthritis Diagnosis Market Key Players

• Antibodies Inc. • Euro Diagnostica AB • Qiagen NV • Siemens Healthcare GmbH • Bio Rad Laboratories Inc. • Genway Biotech, Inc. • Abbott Diagnostics • Beckman Coulter, Inc., • F. Hoffmann-La Roche Ltd. • Thermo Fisher Scientific Inc • Danaher Corporation • Fast Track Diagnostics • Alere, Inc. • Quest Diagnostics • Others
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Treatment 2.3.2. Primary Research 2.3.2.1. Data from Primary Treatment 2.3.2.2. Breakdown of Primary Treatment 3. Executive Summary: Global Rheumatoid Arthritis Diagnosis Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Rheumatoid Arthritis Diagnosis Methods Market 3.4. Geographical Snapshot of the Rheumatoid Arthritis Diagnosis Methods Market, By Manufacturer share 4. Global Rheumatoid Arthritis Diagnosis Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Methods 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Rheumatoid Arthritis Diagnosis Market 5. Supply Side and Demand Side Indicators 6. Global Rheumatoid Arthritis Diagnosis Market Analysis and Forecast, 2019-2026 6.1 Rheumatoid Arthritis Diagnosis Market Size & Y-o-Y Growth Analysis 7. Global Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 7.1.1. Serology Tests 7.1.1.1 Erythrocyte Sedimentation rate 7.1.1.2 Anti-Cyclic Citrullinated Peptide 7.1.1.3 Rheumatoid Factor 7.1.1.4 Antinuclear Antibody 7.1.1.5 Image Testing 7.1.1.6 Blood Test 7.1.1.7 Uric Acid 7.1.1.8 Others 7.1.2. Monitoring Rheumatoid Arthritis Treatment Efficiency Tests 7.1.2.1 Muscle Enzyme Tests 7.1.2.2 Salicylate Level Count 7.1.2.2 Creatinine Test 7.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 7.2.1. Hospitals 7.2.2. Diagnostic Clinics 7.2.3. Ambulatory Surgical Centers 8. Market Size (Value) Estimates & Forecast by Region, 2019-2026 8.1.1. North America 8.1.2. South America 8.1.3. Europe 8.1.4. Asia Pacific 8.1.5. Middle East and Africa 9. North America Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 9.1.1. Serology Tests 8.1.1.1 Erythrocyte Sedimentation rate 8.1.1.2 Anti-Cyclic Citrullinated Peptide 8.1.1.3 Rheumatoid Factor 8.1.1.4 Antinuclear Antibody 8.1.1.5 Image Testing 8.1.1.6 Blood Test 8.1.1.7 Uric Acid 8.1.1.8 Others 9.1.2. Monitoring Rheumatoid Arthritis Treatment Efficiency Tests 8.1.2.1 Muscle Enzyme Tests 8.1.2.2 Salicylate Level Count 8.1.2.3 Creatinine Test 9.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 9.2.1. Hospitals 9.2.2. Diagnostic Clinics 9.2.3. Ambulatory Surgical Centers 10. North America Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 12. Canada Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 13. Mexico Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 14. Europe Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 15. Europe Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 17. France Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 18. Germany Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 19. Italy Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 19.3. 20. Spain Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 21. Sweden Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 22. CIS Countries Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 23. Rest of Europe Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 24. Asia Pacific Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 25. Asia Pacific Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 27. India Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 28. Japan Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 29. South Korea Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 30. Australia Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 31. ASEAN Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 32. Rest of Asia Pacific Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 33. Middle East Africa Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 34. Middle East Africa Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 36. GCC Countries Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 37. Egypt Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 38. Nigeria Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 39. Rest of ME&A Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 40. South America Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 41. South America Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 43. Argentina Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 44. Rest of South America Rheumatoid Arthritis Diagnosis Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Method, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By End User, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Rheumatoid Arthritis Diagnosis Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Treatments and R&D Investment 45.2.2. New Method Launches and Method Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Siemens Healthcare GmbH 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Method Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2 Antibodies Inc. 45.3.3 Euro Diagnostica AB 45.3.4 Qiagen NV 45.3.5 Bio Rad Laboratories Inc. 45.3.6 Genway Biotech, Inc. 45.3.7 Abbott Diagnostics 45.3.8 Beckman Coulter, Inc., 45.3.9 F. Hoffmann-La Roche Ltd. 45.3.10 Thermo Fisher Scientific Inc 45.3.11 Danaher Corporation 45.3.12 Fast Track Diagnostics 45.3.13 Alere, Inc. 45.3.14 Quest Diagnostics 45.3.15 Others 46 Primary Key Insights

About This Report

Report ID 112472
Category Healthcare
Published Date Jul 2021
Updated Date
Contact Us